VCU Stravitz-Sanyal Institute for Liver Disease

Congratulations, @ArunJSanyalVCU!

😲 😲 @ArunJSanyalVCU helped to inaugurate the new Liver and Kidney Transplant Operation Theater Complex and an advanced ICU block of VGM Hospital, Coimbatore, India. bit.ly/455m4Qv #livertwitter #MASH #LT

🗞️ READ ALL ABOUT IT. Updates from the institute and news about our faculty and staff are in the July edition of the SSI newsletter. bit.ly/3IKelj4

Thanks to @inside_PM for the opportunity for @jasmohanbajaj to talk about new paper, AI Foresees Death After Cirrhosis Hospitalization insideprecisionmedicine.com/topics/patient…

🆕 In @AGA_Gastro, a global research team reports how it used AI to improve prediction of death risk for hospitalized cirrhosis patients. The machine-learning model outscored older methods and is available online. #livertwitter @RichmondVAMC @JasmohanBajaj bit.ly/4m8aI51

🤖🧠 An AI model accurately predicted inpatient death on day 1 of admission in patients with #cirrhosis. Developed by @JasmohanBajaj and colleagues @VCU, and published in @AGA_Gastro — it may help guide timely, individualized decisions. #LiverHealth bit.ly/3H3elu1

And @juanpabloarab

The 2025 EASL #SLDsummit content is now available on demand is now accessible on demand for all users with a MyEASL account. Re-discover the sessions and ePosters on EASL Campus! 🔗 easlcampus.eu/list-search-ta… #LiverX #LiverTwitter

📣#MetALD: An Emerging Diagnosis Changing #ALD Care Pre- & Post-Transplant, featuring, leading expert, Dr. Juan Pablo Arab, 07/24, 8pm ET on Zoom. Share with patients! To receive an invite, join our no-cost community! bit.ly/3IFhLnm #LiverTwitter #Cirrhosis #FattyLiver

Thanks to @VirginiaHHA for this opportunity for @ArunJSanyalVCU to discuss the benefits of semaglutide for liver patients.

Are you vaccinated against hepatitis A and B?

If you're looking for a world-renowned GI fellowship program, listen/watch @ArunJSanyalVCU discuss the VCU program: No. 9 worldwide, No. 4 in the U.S. and No. 1 in the South. See what we're about. bit.ly/4lWbZfh

Definitions of #liver failure vary➡️tower of Babel in #ACLF Enter @CLEARED_liver with 🌎 input (>120 sites) @AGA_CGH 🔑 liver failure=bili >7.5, INR>1.5 & grade2 #HE ➡️ death 🔑 validated in @MayoClinicGIHep pubmed.ncbi.nlm.nih.gov/40618943/ Informed pubmed.ncbi.nlm.nih.gov/40499736/ @AGA_Gastro

.@richsterlingMD, our CCO, leads VCU review of Novel NITs for Liver Fibrosis: Moving Beyond Simple Tests in MASLD. NILDAs are effective alternatives to liver biopsy for fibrosis assessment in MASLD - Clinical Gastroenterology and Hepatology bit.ly/3IKmjso

#MASLD Deaths Expected to Rise Sharply by 2040 bit.ly/4eO791v via @pozmagazine

Cardiovascular Risk Assessment Tools are Insufficient for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Barritt, et al. 📕 doi.org/10.14309/ajg.0…   @sidbarritt4 @ebtapper @DrLoomba @ArunJSanyalVCU @TargetRWE @MLongMD @JasmohanBajaj

2025 @VCU_Liver 'MASH school' welcomed endocrinologists and hepatologists from Brazil for a 2-day intensive course to strengthen their skills in diagnosing and managing MASH 💪 Grateful to my gurus @ArunJSanyalVCU @RichSterlingMD for the opportunity to present to this…

VCU's School of Medicine announced that our chief clinical officer, @RichSterlingMD, MSc, FACG, AGAF, FAASLD, will serve as the Department of Internal Medicine’s associate chair for research. He has served as the assistant chair for research for the past 5 years. #livertwitter

This week's @VirginiaHHA podcast features Dr. Saul Karpen, our Chief Scientific Officer. 👂to a discussion about his research to overcome a life-threatening liver disease in infants. bit.ly/3IgOmzA #livertwitter @saulkarpen @ArunJSanyalVCU @AASLDtweets

Hey, @livertwitter. Here's the 2025 class photo from "MASH School" at the Institute. The two-day seminar of intensive lectures and discussions kicked off this morning, with about 20 hepatologists from Brazil participating. @usponline @ArunJSanyalVCU bit.ly/49vymBV